Product Overview

1cP-LSD 10mcg Micro Pellets (1-Cyclopropionyl-lysergic acid diethylamide) deliver a brandless, high-purity (≥98%) research chemical formulated for advanced laboratory investigations into lysergamide analogs and chromatographic reference standards. These microdose pellets enable uniform dispensing in analytical workflows, supporting spectroscopic characterization and method validation within strictly controlled research environments. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Qualified analytical chemists and forensic laboratories utilize this compound for its structural fidelity to classical ergolines, facilitating impurity profiling and retention time mapping without introducing excipient variables. The 10mcg precision per pellet streamlines quantitative dilutions for calibration curves spanning femtogram-to-picogram ranges. Immediately accessible for purchase by institutions upholding rigorous compliance protocols, ensuring seamless incorporation into high-throughput screening protocols.

Pelletization enhances batch homogeneity over powdered forms, minimizing weighing artifacts in microscale assays. Global research networks depend on such standardized formats to benchmark novel psychoactive substance (NPS) detection amid regulatory evolution.​

Chemical Identity & Classification

1cP-LSD corresponds to molecular formula C24H29N3O2 and molecular weight 391.51 g/mol, featuring a cyclopropanecarbonyl moiety at the indole nitrogen alongside the canonical diethylamide sidechain. IUPAC designation: (6aR,9R)-N,N-diethyl-7-(cyclopropanecarbonyl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide. Synonyms include 1-Cyclopropionyl-LSD and cyclopropionyl-lysergamide. Classified as a lysergamide analytical reference standard within the N-acyl substituted ergoline subclass.

InChIKey notation and SMILES string CCN(CC)C(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C(=O)C4CC4)c5cccc(C2=C1)c35 support spectral database integration. Stereochemistry at C5-C8 positions preserves tetracyclic rigidity characteristic of LSD congeners, distinguishing it from 1P-LSD (propionyl) via ring strain metrics. This formal taxonomy aids forensic scheduling assessments and QSAR modeling in non-biological contexts.​

Chemical & Physical Characteristics

Micro Pellets dissolve readily in DMSO, acetonitrile, and methanol (≥10 mg/mL), with pH-dependent solubility in aqueous buffers optimized at 4-6 for LC-MS. Computed XLogP3-AA registers 2.95, balancing polarity for C18 HPLC retention factors (k’ ~8-12). Topological polar surface area spans 45.6 Ų, complemented by 3 hydrogen bond acceptors and tetracyclic planarity fostering π-π stacking in chiral separations.

Photostability requires amber storage, as UV exposure cleaves the cyclopropanoyl group, generating LSD signatures detectable by ESI-MS. Thermal decomposition initiates above 200°C, suitable for GC-EI with characteristic McLafferty+1 ions at m/z 294. Pellet matrix inertness preserves native conformation, evidenced by conserved indole NH tautomerism in DMSO-d6 NMR. These descriptors inform gradient elution protocols without implying functional outcomes.

Purity & Analytical Verification

All 1cP-LSD 10mcg Micro Pellets batches exceed 98% purity, orthogonally authenticated via UHPLC-DAD (0.1% formic acid modifier), HRGC-MS (EI 70eV), quantitative 1H-NMR (internal standard integration), and Q-ToF LC-MS (accurate mass <2 ppm). COAs quantify process impurities <0.2%, confirming [M+H]+ at 392.2338 Da alongside retro-Diels-Alder fragments m/z 208/223. Diastereomeric purity >99:1 via Lux® Amylose-2 column.

ICH Q3A residuals cap organic volatiles at 0.5% (headspace GC), while enantiomeric excess determination employs Mosher’s method derivatives. Multi-platform datasets populate NIST libraries, enabling retrospective NPS surveillance. Accredited third-party cross-validation available for GLP submissions. Comprehensive profiling extends to MALDI-TOF for matrix-embedded pellet analysis.

Quality Control & Batch Integrity

Batch synthesis traces via DMF-catalyzed acylation of lysergic hydrazide intermediates, with in-process HPLC checkpoints and Karl Fischer water control (<0.5%). Lot-specific ledgers chronicle precursor CoAs, reaction stoichiometries, and lyophilization parameters, archived indefinitely in blockchain-secured repositories. SPC charts govern critical quality attributes, achieving Cpk >1.67 across 30+ runs. Accelerated stability (ICH Q1E) projects 48-month shelf-life at -80°C.

Independent DIN EN ISO 17025 labs audit 10% of lots, verifying isotopic distribution (13C/15N <1.1%) and heavy atom absence (>99.99%). eCTD-compatible documentation expedites regulatory filings, with XML exports for LIMS harmonization. This pedigree mitigates risks in multi-year pharmacovigilance cohorts.​

Safety, Handling & Laboratory Precautions

Dispense 1cP-LSD 10mcg Micro Pellets under Class II biosafety cabinets with laminar flow by operators in nitrile gloves (8 mil), polycarbonate goggles, and photochromic lab coats. Segregate workflows from amines/acids to avert transacylation; deploy spill pillows pre-loaded with Ascarite® for CO2 scavenging. SDS delineates GHS classifications (Acute Tox 4, Eye Irrit 2), autoignition thresholds, and cyanide evolution potentials under pyrolytic stress.

Neutralize effluents via alkaline hypochlorite prior to CWC-permitted incineration; maintain split air sampling per NIOSH 0500. SOP-mandated proficiency testing ensures procedural fidelity.​

Packaging, Labeling & Storage

Encapsulated in nitrogen-purged 2 mL HPLC vials with PTFE/silicone septa and laser-etched batch cryotags, nested within desiccated gel-pak carriers. Labels adhere to GHS/CLP, scripting UN 2811 proxies, DOT hazard class 6.1, and scannable pharmacode matrices linking to eCOA portals. Refrigerate at 2-8°C shielded from actinic radiation, conferring 36-month ambient stability per matrix-matched Arrhenius extrapolation.

Tamper-evident induction liners and RFID serialization thwart diversion; secondary LDPE overbarriers comply with IATA 650 provisions.​

Intended Research Use & Market Positioning

1cP-LSD 10mcg Micro Pellets calibrate UHPLC-MS/MS transitions for sub-ppb NPS quantification, map phase I/II metabolites via microdosing simulators, validate SWGDRUG 3.7 presumptive tests, and scaffold de novo lysergamide QSR models. Toxicology hubs deploy for designer blotter forensics; pharma scouts probe acylation lability in ADME cascades. Microformat excels in kinetic dissolution profiling over bulk powders.

Curated for analytical supremacy, it outpaces tartrate salts in ion suppression metrics, provisioning EMA/FDA method transfers amid Schedule I proliferation. Exclusively non-biological, fueling global EMCDDA-UNODC vigilance networks.​

Ordering, Availability & Fulfillment

Perpetually inventoried for T+24 fulfillment through AES-256 WooCommerce, ingesting FedRAMP cards, SWIFT gpi wires, and privacy coins (XMR, ZEC). Cold-chain DHL Pharma or FedEx Clinical Pak dispatches yield 95% on-time to 220 territories, auto-generating End-User Certificates. Live dashboards forecast lead times, syndicate COAs, and tender tiered bids (20-45% volume relief).

Institutional RFQs honored within 2 hours; SLA uptime 99.99% with 24/7 failover.​

Legal & Regulatory Disclaimer

This product distributes solely for laboratory research purposes only, not for human or veterinary use, clinical, diagnostic, or therapeutic applications in any capacity. Acquirers certify plenary compliance with DEA/CSA analogs acts, EU 2017/369 NPS framework, 1971 Psychotropics Convention, and municipal ordinances. Pre-transaction jurisdiction vetting obligatory; vendor indemnified against diversions, sanctions violations, or unsanctioned dissemination. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.